ARCHIVES

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

This article is from The Cancer Letter archive.

Vol. 33 No. 01 | January 12, 2007

Download PDF Visit The Full Archive

Related Articles

New Frederick Contract Drops Slightly From ‘75

July 11, 1975

FDA Recruiting ODAC Consumer Rep Candidates

March 31, 1995

CAP Issues Active Surveillance Guidance For Prostate Cancer

September 5, 2014

Nurse Oncology Society Growing, developing Care Guidelines

August 19, 1977

FDA Approves Abbott’s HER-2 DNA Probe Kit.

January 25, 2002

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992